Synjardy XR 1000 mg/1

Synjardy XR 1000 mg/1 combines empagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Synjardy XR 1000 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. It works by combining two active ingredients, empagliflozin and metformin hydrochloride, to improve glycemic control. This medication is typically used as part of a broader diabetes management plan, which may include diet and exercise. People often ask, 'What is Synjardy XR used for?' and the answer is that it is primarily used to help control blood sugar levels in type 2 diabetes.

Common effects of Synjardy XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or genital mycotic infections. These effects can vary from person to person and may subside over time.

Synjardy XR 1000 mg/1 should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication as directed and keep it out of reach of children.

Synjardy XR 1000 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol and certain other substances may also affect how this medication works.